{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:13:53Z","timestamp":1788473633182,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["ZIA HD008989"],"award-info":[{"award-number":["ZIA HD008989"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Niemann\u2013Pick disease type C1 (NPC1) is a rare autosomal recessive disease characterized by endolysosomal accumulation of unesterified cholesterol with progressive deterioration in swallowing, often leading to premature death. Although documented, the natural history of NPC1 swallowing dysfunction has yet to be delineated systematically. This manuscript aims to provide a comprehensive characterization of the phenotypic spectrum and progression of swallowing dysfunction in NPC1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodology<\/jats:title>\n                <jats:p>The National Institutes of Health (NIH) NPC1 natural history study (NCT00344331) enrolled 120 patients, who underwent comprehensive interpretative swallow assessments for swallowing safety, dietary modifications, and aspiration risk. Longitudinal statistical modeling accounted for all outcomes with NPC1 disease covariates (first symptom onset, age at neurological symptom onset, seizure history, duration of neurological symptoms) as well as miglustat use (a glucosylceramide synthase inhibitor) and NIH study duration (NIHSD; the length of time an individual participated in the NIH study). Probabilities for disease progression and time to swallowing decline were conducted for the entire cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Time to swallowing decline with American Speech-Language-Hearing Association National Outcome Measure (ASHA-NOMS) and the NIH-adapted Penetration Aspiration Scale (NIH-PAS) were identified: <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\frac{7.7}{100}$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                    <mml:mfrac>\n                      <mml:mrow>\n                        <mml:mn>7.7<\/mml:mn>\n                      <\/mml:mrow>\n                      <mml:mn>100<\/mml:mn>\n                    <\/mml:mfrac>\n                  <\/mml:math><\/jats:alternatives><\/jats:inline-formula> person-years and <jats:inline-formula><jats:alternatives><jats:tex-math>$$\\frac{9.8}{100}$$<\/jats:tex-math><mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                    <mml:mfrac>\n                      <mml:mrow>\n                        <mml:mn>9.8<\/mml:mn>\n                      <\/mml:mrow>\n                      <mml:mn>100<\/mml:mn>\n                    <\/mml:mfrac>\n                  <\/mml:math><\/jats:alternatives><\/jats:inline-formula> person-years, respectively. NIHSD and seizure history consistently and significantly were associated with decline (<jats:italic>OR<\/jats:italic><jats:sub><jats:italic>NIHSD<\/jats:italic><\/jats:sub>\u2009=\u20091.34\u20132.10, 95% <jats:italic>CI<\/jats:italic> 1.04\u20133.4, <jats:italic>p<\/jats:italic>\u2009=\u20090.001\u20130.026; <jats:italic>OR<\/jats:italic><jats:sub><jats:italic>Seizure<\/jats:italic><\/jats:sub>\u2009=\u20093.26\u201318.22, 1.03\u2013167.79; <jats:italic>p<\/jats:italic>\u2009=\u20090.001\u20130.046), while miglustat use revealed protection (<jats:italic>OR<\/jats:italic><jats:sub><jats:italic>Miglustat<\/jats:italic><\/jats:sub>\u2009=\u20090.01\u20130.43, 0.007\u20130.98; <jats:italic>p<\/jats:italic>\u2009=\u20090.001\u20130.044). The probability of decline with NPC1 neurological severity scale and annual severity increment scale were established with the aforementioned covariates, varying amongst subgroups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study represents the most extensive collection of prospective, instrumental swallowing assessments in NPC1 to date with an interpretive analysis providing an improved understanding of NPC1 disease progression with swallowing function\u2014serving as a foundation for clinical management and future NPC1 therapeutics.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02472-w","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T18:02:34Z","timestamp":1662400954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Phenotypic expression of swallowing function in Niemann\u2013Pick disease type C1"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0978-7714","authenticated-orcid":false,"given":"Beth I.","family":"Solomon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninet","family":"Sinaii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bianconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Dang Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Backman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonza","family":"Machielse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forbes D.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"issue":"1","key":"2472_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/gim.2015.25","volume":"18","author":"CA Wassif","year":"2016","unstructured":"Wassif CA, Cross JL, Iben J, et al. High incidence of unrecognized visceral\/neurological late-onset Niemann\u2013Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets. Genet Med. 2016;18(1):41\u20138. https:\/\/doi.org\/10.1038\/gim.2015.25.","journal-title":"Genet Med"},{"issue":"1\u20133","key":"2472_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s1388-1981(00)00158-x","volume":"1529","author":"DS Ory","year":"2000","unstructured":"Ory DS. Niemann\u2013Pick type C: a disorder of cellular cholesterol trafficking. Biochim Biophys Acta. 2000;1529(1\u20133):331\u20139. https:\/\/doi.org\/10.1016\/s1388-1981(00)00158-x.","journal-title":"Biochim Biophys Acta"},{"key":"2472_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-5-16","volume":"5","author":"MT Vanier","year":"2010","unstructured":"Vanier MT. Niemann\u2013Pick disease type C. Orphanet J Rare Dis. 2010;5:16. https:\/\/doi.org\/10.1186\/1750-1172-5-16.","journal-title":"Orphanet J Rare Dis"},{"key":"2472_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1750-1172-7-76","volume":"7","author":"M Walterfang","year":"2012","unstructured":"Walterfang M, Chien YH, Imrie J, Rushton D, Schubiger D, Patterson MC. Dysphagia as a risk factor for mortality in Niemann\u2013Pick disease type C: systematic literature review and evidence from studies with miglustat. Orphanet J Rare Dis. 2012;7:76. https:\/\/doi.org\/10.1186\/1750-1172-7-76.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2472_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/bf00417897","volume":"11","author":"JC Rosenbek","year":"1996","unstructured":"Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia. 1996;11(2):93\u20138. https:\/\/doi.org\/10.1007\/bf00417897.","journal-title":"Dysphagia"},{"issue":"3","key":"2472_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00455-005-0018-9","volume":"20","author":"D Ramsey","year":"2005","unstructured":"Ramsey D, Smithard D, Kalra L. Silent aspiration: What do we know? Dysphagia. 2005;20(3):218\u201325. https:\/\/doi.org\/10.1007\/s00455-005-0018-9.","journal-title":"Dysphagia"},{"key":"2472_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12245","author":"MC Patterson","year":"2020","unstructured":"Patterson MC, Garver WS, Giugliani R, et al. Long-term survival outcomes of patients with Niemann\u2013Pick disease type C receiving miglustat treatment: a large retrospective observational study. J Inherit Metab Dis. 2020. https:\/\/doi.org\/10.1002\/jimd.12245.","journal-title":"J Inherit Metab Dis"},{"key":"2472_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1172-8-12","volume":"8","author":"MC Patterson","year":"2013","unstructured":"Patterson MC, Mengel E, Wijburg FA, et al. Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis. 2013;8:12. https:\/\/doi.org\/10.1186\/1750-1172-8-12.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2472_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13023-019-0996-6","volume":"14","author":"M Pineda","year":"2019","unstructured":"Pineda M, Jur\u00ed\u010dkov\u00e1 K, Karimzadeh P, et al. Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann\u2013Pick disease Type C: an international, multicenter, retrospective chart review. Orphanet J Rare Dis. 2019;14(1):32. https:\/\/doi.org\/10.1186\/s13023-019-0996-6.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2472_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/ajmg.b.30969","volume":"153B","author":"NM Yanjanin","year":"2010","unstructured":"Yanjanin NM, Velez JI, Gropman A, et al. Linear clinical progression, independent of age of onset, in Niemann\u2013Pick disease, type C. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(1):132\u201340. https:\/\/doi.org\/10.1002\/ajmg.b.30969.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"2472_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13023-018-0880-9","volume":"13","author":"M Cortina-Borja","year":"2018","unstructured":"Cortina-Borja M, Te Vruchte D, Mengel E, et al. Annual severity increment score as a tool for stratifying patients with Niemann\u2013Pick disease type C and for recruitment to clinical trials. Orphanet J Rare Dis. 2018;13(1):143. https:\/\/doi.org\/10.1186\/s13023-018-0880-9.","journal-title":"Orphanet J Rare Dis"},{"key":"2472_CR12","unstructured":"ASHA AS-L-HA. Dysarthria."},{"key":"2472_CR13","first-page":"xiii, 406","volume-title":"Evaluation and treatment of swallowing disorders","author":"JA Logemann","year":"1998","unstructured":"Logemann JA. Evaluation and treatment of swallowing disorders. 2nd ed. Austin: PRO-ED; 1998. p. xiii, 406.","edition":"2"},{"key":"2472_CR14","volume-title":"National outcomes measurement system: adults in healthcare-inpatient rehab national data report 2019","author":"AS-L-H Association","year":"2019","unstructured":"Association AS-L-H. National outcomes measurement system: adults in healthcare-inpatient rehab national data report 2019. Rockville: National Center for Evidence-Based Practice in Communication Disorders; 2019."},{"key":"2472_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijporl.2015.11.009","volume":"80","author":"RT Senirli","year":"2016","unstructured":"Senirli RT, Ku\u015f\u00e7u O, Akyol U, et al. Otorhinolaryngological, audiovestibular and swallowing manifestations of patients with Niemann\u2013Pick disease Type C. Int J Pediatr Otorhinolaryngol. 2016;80:1\u20134. https:\/\/doi.org\/10.1016\/j.ijporl.2015.11.009.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"3","key":"2472_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00455-020-10145-8","volume":"36","author":"C Lewis","year":"2021","unstructured":"Lewis C, Keage M, Watanabe M, et al. Characterization of dysphagia and longitudinal changes in swallowing function in adults with Niemann\u2013Pick disease type C treated with miglustat. Dysphagia. 2021;36(3):362\u201373. https:\/\/doi.org\/10.1007\/s00455-020-10145-8.","journal-title":"Dysphagia"},{"issue":"5","key":"2472_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/dbp.0000000000000785","volume":"41","author":"A Thurm","year":"2020","unstructured":"Thurm A, Chlebowski C, Joseph L, et al. Neurodevelopmental characterization of young children diagnosed with Niemann\u2013Pick disease, type C1. J Dev Behav Pediatr. 2020;41(5):388\u201396. https:\/\/doi.org\/10.1097\/dbp.0000000000000785.","journal-title":"J Dev Behav Pediatr"},{"key":"2472_CR18","doi-asserted-by":"publisher","DOI":"10.1242\/dev.189019","author":"BR Boyle","year":"2020","unstructured":"Boyle BR, Melli SE, Altreche RS, et al. NPC1 deficiency impairs cerebellar postnatal development of microglia and climbing fiber refinement in a mouse model of Niemann\u2013Pick disease type C. Development. 2020. https:\/\/doi.org\/10.1242\/dev.189019.","journal-title":"Development"},{"issue":"1","key":"2472_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.physbeh.2007.01.018","volume":"91","author":"JB Palmer","year":"2007","unstructured":"Palmer JB, Hiiemae KM, Matsuo K, Haishima H. Volitional control of food transport and bolus formation during feeding. Physiol Behav. 2007;91(1):66\u201370. https:\/\/doi.org\/10.1016\/j.physbeh.2007.01.018.","journal-title":"Physiol Behav"},{"issue":"4","key":"2472_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/bf02493469","volume":"7","author":"JB Palmer","year":"1992","unstructured":"Palmer JB, Rudin NJ, Lara G, Crompton AW. Coordination of mastication and swallowing. Dysphagia. 1992;7(4):187\u2013200. https:\/\/doi.org\/10.1007\/bf02493469.","journal-title":"Dysphagia"},{"issue":"3","key":"2472_CR21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s00455-008-9204-x","volume":"24","author":"SB Leder","year":"2009","unstructured":"Leder SB, Suiter DM, Lisitano Warner H. Answering orientation questions and following single-step verbal commands: effect on aspiration status. Dysphagia. 2009;24(3):290\u20135. https:\/\/doi.org\/10.1007\/s00455-008-9204-x.","journal-title":"Dysphagia"},{"issue":"2","key":"2472_CR22","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00429-017-1535-7","volume":"223","author":"I Jestrovi\u0107","year":"2018","unstructured":"Jestrovi\u0107 I, Coyle JL, Perera S, Sejdi\u0107 E. Influence of attention and bolus volume on brain organization during swallowing. Brain Struct Funct. 2018;223(2):955\u201364. https:\/\/doi.org\/10.1007\/s00429-017-1535-7.","journal-title":"Brain Struct Funct"},{"key":"2472_CR23","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.3241","author":"BI Solomon","year":"2020","unstructured":"Solomon BI, Smith AC, Sinaii N, et al. Association of miglustat with swallowing outcomes in Niemann\u2013Pick disease, type C1. JAMA Neurol. 2020. https:\/\/doi.org\/10.1001\/jamaneurol.2020.3241.","journal-title":"JAMA Neurol"},{"issue":"5","key":"2472_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/NEN.0b013e31825414a6","volume":"71","author":"VM Stein","year":"2012","unstructured":"Stein VM, Crooks A, Ding W, et al. Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann\u2013Pick disease type C. J Neuropathol Exp Neurol. 2012;71(5):434\u201348. https:\/\/doi.org\/10.1097\/NEN.0b013e31825414a6.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"2472_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13023-021-01719-2","volume":"16","author":"MC Patterson","year":"2021","unstructured":"Patterson MC, Lloyd-Price L, Guldberg C, et al. Validation of the 5-domain Niemann\u2013Pick type C clinical severity scale. Orphanet J Rare Dis. 2021;16(1):79. https:\/\/doi.org\/10.1186\/s13023-021-01719-2.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2472_CR26","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s13023-021-02115-6","volume":"16","author":"W Evans","year":"2021","unstructured":"Evans W, Patterson M, Platt F, Guldberg C, Mathieson T, Pacey J. International consensus on clinical severity scale use in evaluating Niemann\u2013Pick disease type C in paediatric and adult patients: results from a Delphi Study. Orphanet J Rare Dis. 2021;16(1):482. https:\/\/doi.org\/10.1186\/s13023-021-02115-6.","journal-title":"Orphanet J Rare Dis"},{"key":"2472_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2021.11.009","author":"N Farhat","year":"2021","unstructured":"Farhat N, Bailey L, Friedmann K, et al. Consistently high agreement between independent raters of Niemann\u2013Pick type C1 clinical severity scale in phase 2\/3 trial. Pediatr Neurol. 2021. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2021.11.009.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"2472_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","volume":"13","author":"T Geberhiwot","year":"2018","unstructured":"Geberhiwot T, Moro A, Dardis A, et al. Consensus clinical management guidelines for Niemann\u2013Pick disease type C. Orphanet J Rare Dis. 2018;13(1):50. https:\/\/doi.org\/10.1186\/s13023-018-0785-7.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2472_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13023-019-0996-6","volume":"14","author":"M Pineda","year":"2019","unstructured":"Pineda M, Jurickova K, Karimzadeh P, et al. Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann\u2013Pick disease Type C: an international, multicenter, retrospective chart review. Orphanet J Rare Dis. 2019;14(1):32. https:\/\/doi.org\/10.1186\/s13023-019-0996-6.","journal-title":"Orphanet J Rare Dis"},{"key":"2472_CR30","doi-asserted-by":"publisher","unstructured":"Pineda M, Jurickova K, Karimzadeh P, et al. Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review. Orphanet J Rare Dis. 2019;14(1):32. https:\/\/doi.org\/10.1186\/s13023-019-0996-6.","DOI":"10.1186\/s13023-019-0996-6"},{"key":"2472_CR31","doi-asserted-by":"publisher","unstructured":"Patterson MC, Mengel E, Vanier MT, Moneuse P, Rosenberg D, Pineda M. Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry. Orphanet J Rare Dis. 2020;15(1):104. https:\/\/doi.org\/10.1186\/s13023-020-01363-2.","DOI":"10.1186\/s13023-020-01363-2"},{"issue":"1","key":"2472_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13023-020-01363-2","volume":"15","author":"MC Patterson","year":"2020","unstructured":"Patterson MC, Mengel E, Vanier MT, Moneuse P, Rosenberg D, Pineda M. Treatment outcomes following continuous miglustat therapy in patients with Niemann\u2013Pick disease type C: a final report of the NPC registry. Orphanet J Rare Dis. 2020;15(1):104. https:\/\/doi.org\/10.1186\/s13023-020-01363-2.","journal-title":"Orphanet J Rare Dis"},{"key":"2472_CR33","doi-asserted-by":"publisher","unstructured":"Patterson MC, Lloyd-Price L, Guldberg C, et al. Validation of the 5-domain Niemann-Pick type C clinical severity scale. Orphanet J Rare Dis. 2021;16(1):79. https:\/\/doi.org\/10.1186\/s13023-021-01719-2.","DOI":"10.1186\/s13023-021-01719-2"},{"key":"2472_CR34","doi-asserted-by":"publisher","unstructured":"Evans W, Patterson M, Platt F, Guldberg C, Mathieson T, Pacey J. International consensus on clinical severity scale use in evaluating Niemann-Pick disease Type C in paediatric and adult patients: results from a Delphi Study. Orphanet J Rare Dis. 2021;16(1):482. https:\/\/doi.org\/10.1186\/s13023-021-02115-6.","DOI":"10.1186\/s13023-021-02115-6"},{"key":"2472_CR35","doi-asserted-by":"publisher","unstructured":"Farhat N, Bailey L, Friedmann K, et al. Consistently high agreement between independent raters of Niemann-Pick type C1 clinical severity scale in phase 2\/3 trial. Pediatr Neurol. 2022;127:32\u201338. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2021.11.009.","DOI":"10.1016\/j.pediatrneurol.2021.11.009"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02472-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02472-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02472-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T18:15:45Z","timestamp":1662401745000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02472-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2472"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02472-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients were enrolled under an NIH-IRB approved study with provision of informed consent\/assent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"342"}}